Renal effects of selective cyclooxygenase inhibition in experimental liver disease

Adv Exp Med Biol. 2003:525:133-6. doi: 10.1007/978-1-4419-9194-2_27.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carbon Tetrachloride / pharmacology
  • Chemical and Drug Induced Liver Injury
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / pharmacology*
  • Disease Models, Animal
  • Gene Expression Regulation / drug effects*
  • Glomerular Filtration Rate / drug effects
  • Isoenzymes / genetics
  • Isoenzymes / metabolism
  • Kidney / drug effects*
  • Kidney / physiopathology*
  • Liver Diseases / drug therapy*
  • Liver Diseases / genetics
  • Male
  • Membrane Proteins
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar

Substances

  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • RNA, Messenger
  • Carbon Tetrachloride
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • Ptgs1 protein, rat